The breast reconstruction market comprises implants and tissue expanders used in reconstructive breast surgeries. Implants and tissue expanders help recreate a natural, sustainable breast shape for patients who have undergone mastectomy due to breast cancer or other illnesses. Breast reconstructive surgery helps restore confidence and quality of life.
The global breast reconstruction market is estimated to be valued at US$ 2.4 billion in 2024 and is expected to exhibit a CAGR of 7.0% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Growing acceptance of reconstructive breast surgery procedures has propelled the breast reconstruction market growth. The reconstructive procedure options help address both physical and psychological impacts of mastectomy. Positive perception of reconstructive breast surgery as a important part of cancer treatment is growing. This is encouraging more patients to consider the procedures. As per recent studies, over 80% of eligible patients now choose to undergo breast reconstruction. Increased awareness about availability of reconstruction options and its benefits is supporting this evolving trend.
SWOT Analysis
Strength: Breast reconstruction surgery has higher patient satisfaction rate and improves quality of life by rebuilding self-esteem and confidence. It provides the option to choose from a variety of surgical techniques as per individual preference and needs.
Weakness: Reconstruction procedures involve multiple surgeries which increases surgical risks and costs. The recovery period is also longer. Certain techniques have issues related to forming natural breast shape and size.
Opportunity: Rising incidence of breast cancer creates the need for reconstruction among young women. Growing breast aesthetics market increases awareness about reconstruction benefits. Developing techniques improve results and patient experience.
Threats: Lack of awareness in developing regions. Social stigma and misconceptions discourage women from opting for reconstruction in parts of Asia and Africa. Complications and high costs are deterrents for some patients.
Key Takeaways
The global breast reconstruction market is expected to witness high growth driven by increasing breast cancer incidence and rising awareness. The global breast reconstruction market is estimated to be valued at US$ 2.4 billion in 2024 and is expected to exhibit a CAGR of 7.0% over the forecast period 2024-2031.
North America dominates due to high diagnosis rates, favourable reimbursements and growing cosmetic procedures market. The US accounted for the largest share in 2020 with over 50% of the regional market owing to well-developed healthcare infrastructure and supportive patient programmes.
Key players operating in the breast reconstruction market are Allergan, Mentor Worldwide LLC, Sientra Inc., GC Aesthetics, POLYTECH Health & Aesthetics and Hanson Medical Inc. There is increasing collaboration between manufacturers and surgeons to develop new techniques and tissue expansion solutions. 3D printing and biologics are projected enhance reconstruction outcomes and customisation options. Many companies are also investing in robotics and AI based platforms to perform complex procedures with greater accuracy.
*Note:
- Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
